Fresh embryo transfer may improve IVF success for women with low prognosis

A House pan­el is prob­ing the FDA over how it has al­lowed a com­mon in­gre­di­ent in over-the-counter cold med­ica­tions to stay on the mar­ket for

Bris­tol My­ers Squibb re­port­ed a Phase 3 suc­cess and a pipeline cut as part of its sec­ond-quar­ter earn­ings Fri­day morn­ing. The com­pa­ny said a piv­otal

Apel­lis Phar­ma­ceu­ti­cals is in cash-sav­ing mode as it looks to ward off a new­ly-mint­ed com­peti­tor in treat­ing a lead­ing cause of blind­ness. The drug­mak­er said